Showing results (11-20 of 231,054) with videos related to
Sort By:
Pageof 23,106
Pediatrics|April 9, 1998
Effectiveness and cost-effectiveness of letters, automated telephone messages, or both for underimmunized children in a health maintenance organizationT A Lieu, A M Capra, J Makol, et al.The Pediatric Infectious Disease Journal|January 1, 1997
Computer-generated recall letters for underimmunized children: how cost-effective?T A Lieu, S B Black, P Ray, et al.Pediatrics|May 1, 1995
Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescentsT A Lieu, L J Finkler, M E Sorel, et al.European Journal of Pediatrics|December 21, 2002
Safety and efficacy of the seven-valent pneumococcal conjugate vaccine: evidence from Northern CaliforniaSteven Black, Henry ShinefieldThe Pediatric Infectious Disease Journal|May 15, 2002
Efficacy, immunogenicity and safety of heptavalent pneumococcal conjugate vaccine in low birth weight and preterm infantsHenry Shinefield, Steven Black, Paula Ray, et al.The Pediatric Infectious Disease Journal|April 27, 2000
Efficacy of pneumococcal conjugate vaccines in large scale field trialsH R Shinefield, S BlackExpert Review of Vaccines|October 14, 2005
Prevention of Staphylococcus aureus infections: advances in vaccine developmentHenry R Shinefield, Steven BlackThe Pediatric Infectious Disease Journal|November 1, 1995
Postlicensure surveillance for Haemophilus influenzae type b invasive disease after use of Haemophilus influenzae type b oligosaccharide CRM197 conjugate vaccine in a large defined United States population: a four-year eight-month follow-upH R Shinefield, S BlackThe Pediatric Infectious Disease Journal|February 29, 2000
Parents' preferences for outcomes associated with childhood vaccinationsM Kuppermann, R F Nease, L M Ackerson, et al.Pediatrics|March 1, 1987
b-CAPSA I Haemophilus influenzae, type b, capsular polysaccharide vaccine safetyS B Black, H R ShinefieldPageof 23,106